Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock

European Heart Journal

Volumn 31, Issue 24, 2010, Pages 3032-3039

  Den Uil, Corstiaan A ^a   Lagrand, Wim K ^b   Van Der Ent, Martin ^a   Jewbali, Lucia S D ^a   Cheng, Jin M ^a   Spronk, Peter E ^c   Simoons, Maarten L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c GELRE HOSPITALS   (Netherlands)

Author keywords

Cardiogenic shock; Microcirculation; Organ failure; Outcome; Perfusion

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CAPILLARY DENSITY; CARDIOGENIC SHOCK; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TISSUE PERFUSION;

AGED; CAPILLARIES; CORONARY CIRCULATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SUBLINGUAL GLAND;

EID: 78650327426     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq324     Document Type: Article

References (43)

1. Wu AH, Parsons L, Every NR, Bates ER. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 2002;40:1389-1394.
2. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009;119:1211-1219.
3. Cheng JM, Valk SDA, den Uil CA, van der Ent M, Lagrand WK, van de Sande M, van Domburg RT, Simoons ML. Usefulness of intra-aortic balloon pump counter-pulsation in patients with cardiogenic shock from acute myocardial infarction. Am J Cardiol 2009;104:327-332.
4. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-2442.
5. Lim N, Dubois MJ, De Backer D, Vincent JL. Do all nonsurvivors of cardiogenic shock die with a low cardiac index? Chest 2003;124:1885-1891.
6. Cheng JM, Den Uil CA, Hoeks SE, Van der Ent M, Jewbali LS, Van Domburg RT, Serruys PW. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 2009;30:2102-2108.
7. Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, Hochman JS. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 2005;165:1643-1650.
8. Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation 2008;117:686-697.
9. Hasper D, Hummel M, Kleber FX, Reindl I, Volk HD. Systemic inflammation in patients with heart failure. Eur Heart J 1998;19:761-765.
10. Reilly PM, Wilkins KB, Fuh KC, Haglund U, Bulkley GB. The mesenteric hemody-namic response to circulatory shock: an overview. Shock 2001;15:329-343.
11. Smith I, Kumar P, Molloy S, Rhodes A, Newman PJ, Grounds RM, Bennett ED. Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Med 2001;27:74-83.
12. Geppert A, Dorninger A, Delle-Karth G, Zorn G, HeinzG, HuberK. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med 2006;34:2035-2042.
13. Nicholls SJ, Wang Z, Koeth R, Levison B, DelFraino B, Dzavik V, Griffith OW, Hathaway D, Panza JA, Nissen SE, Hochman JS, Hazen SL. Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction. Circulation 2007;116:2315-2324.
14. Jarai R, Fellner B, Haoula D, Jordanova N, Heinz G, Delle-Karth G, Huber K, Geppert A. Early assessment of outcome in cardiogenic shock: Relevance of plasma N-terminal pro-B-type natriuretic peptide and interleuking-6 levels. Crit Care Med 2009;37:1837-1844.
15. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003;107:2998-3002.
16. den Uil CA, Klijn E, Lagrand WK, Brugts JJ, Ince C, Spronk PE, Simoons ML. The microcirculation in health and critical disease. Prog Cardiovasc Dis 2008;51: 161-170.
17. Ware LB, Matthay MA. Measuring microvascular blood flow in sepsis-a continuing challenge. Lancet 2002;360:1187-1188.
18. Struijker-Boudier HA, Rosei AE, Bruneval P, Camici PG, Christ F, Henrion D, Lévy BI, Pries A, Vanoverschelde JL. Evaluation of the microcirculation in hypertension and cardiovascular disease. Eur Heart J 2007;28:2834-2840.
19. Cuschieri J, Rivers EP, Donnino MW, Katilius M, Jacobsen G, Nguyen HB, Pamukov N, Horst HM. Central venous-arterial carbon dioxide difference as an indicator of cardiac index. Intensive Care Med 2005;31:818-822.
20. Goedhart PT, Khalilzada M, Bezemer R, Merza J, Ince C. Sidestream Dark Field (SDF) imaging: a novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation. Opt Express 2007;15:15101-15114.
21. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002;360:1395-1396.
22. De Backer D, Hollenberg S, Boerma C, Goedhart P, Büchele G, Ospina-Tascon G, Dobbe I, Ince C. How to evaluate the microcirculation: report of a round table conference. Crit Care 2007;11:R101.
23. Hubble SM, Kyte HL, Gooding K, Shore AC. Variability in sublingual microvessel density and flow measurements in healthy volunteers. Microcirculation 2009;16: 183-191.
24. Dobbe JG, Streekstra GJ, Atasever B, van Zijderveld R, Ince C. Measurement of functional microcirculatory geometry and velocity distributions using automated image analysis. Med Biol Eng Comput 2008;46:659-670.
25. Den Uil CA, Caliskan K, Lagrand WK, van der Ent M, Jewbali LS, van Kuijk JP, Spronk PE, Simoons ML. Dose-dependent benefit of nitroglycerin on microcircu-lation of patients with severe heart failure. Intensive Care Med 2009;35: 1893-1899.
26. Den Uil CA, Lagrand WK, Spronk PE, van der Ent M, Jewbali LS, Brugts JJ, Ince C, Simoons ML. Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure. Eur J Heart Fail 2009;11:386-390.
27. Den Uil CA, Lagrand WK, Spronk PE, van Domburg RT, Hofland J, Lüthen C, Brugts JJ, van der Ent M, Simoons ML. Impaired sublingual microvascular perfusion during surgery with cardiopulmonary bypass: a pilot study. J Thorac Cardiovasc Surg 2008;136:129-134.
28. Boerma EC, Koopmans M, Konijn A, Kaiferova K, Bakker AJ, van Roon EN, Buter H, Bruins N, Egbers PH, Gerritsen RT, Koetsier PM, Kingma WP, Kuiper MA, Ince C. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial. Crit Care Med 2009;38: 93-100.
29. Den Uil CA, Maat AP, Lagrand WK, van der Ent M, Jewbali LS, van Thiel RJ, Spronk PE, Simoons ML. Mechanical circulatory support devices improve tissue perfusion in patients with end-stage heart failure or cardiogenic shock. J Heart Lung Transpl 2009;28:906-911.
30. Arnold RC, Parrillo JE, Phillip Dellinger R, Chansky ME, Shapiro NI, Lundy DJ, Trzeciak S, Hollenberg SM. Point-of-care assessment of microvascular blood flow in critically ill patients. Intensive Care Med 2009;35:1761-1766.
31. Vincent JL, Angus DC, Artigas A, Kalil A, Basson BR, Jamal HH, Johnson G, Bernard GR. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med 2003;31:834-840.
32. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-710.
33. Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 2004;44:340-348.
34. Garcia-Alvarez A, Arzamendi D, Loma-Osorio P, Kiamco R, Masotti M, Sionis A, Betriu A, Brugada J, Bosch X. Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention. Am J Cardiol 2009;103:1073-1077.
35. Picard MH, Davidoff R, Sleeper LA, Mendes LA, Thompson CR, Dzavik V, Steingart R, Gin K, White HD, Hochman JS. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation 2003; 107:279-284.
36. De Backer D, Creteur J, Dubois MJ, Sakr Y, Vincent JL. Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J 2004; 147:91-99.
37. De Backer D, Ortiz JA, Salgado D. Coupling microcirculation to systemic hemo-dynamics. Curr Opin Crit Care 2010;16:250-254.
38. Kaluski E, Milo-Cotter O, Cotter G. Death and life are in the power of the tongue. Cardiology 2009;114:39-41.
39. Trzeciak S, McCoy JV, Delllinger RP, Arnold RC, Rizzuto M, Abate NL, Shapiro NL, Parillo JE, Hollenberg SM. Early increases in microcirculatory per-fusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008;34: 2210-2217.
40. HasdaiD, Holmes DR, Califf RM, Thompson TD, Hochman JS, Pfisterer M, Topol EJ. Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. Am Heart J 1999;138:21-31.
41. Spanos A, Jhanji S, Vivian-Smith A, Harris T, Pearse RM. Early microvascular changes in sepsis and severe sepsis. Shock 2010;33:387-391.
42. Klijn E, Den Uil CA, Bakker J, Ince C. The heterogeneity of the microcirculation in critical illness. Clin Chest Med 2008;29:643-654.
43. Wan Z, Ristagno G, Sun S, Li Y, Weil MH, Tang W. Preserved cerebral microcir-culation during cardiogenic shock. Crit Care Med 2009;37:2333-2337.